Moreover, there is significant evidence to suggest that whilst the apelin peptide is downregulated in both PAH [14], [15], [16] and HF [17], [18], [19], expression of the receptor remains unchanged and responsive to apelin [15], [20], [21]. The gene discussed is APLN; the disease is pulmonary arterial hypertension.